5 Einträge gefunden

1. Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial

   1. Karakas, Mahir
   2. Akin, Ibrahim
   3. Burdelski, Christoph
   4. Clemmensen, Peter
   5. Grahn, Hanno
   6. Jarczak, Dominik
   7. Keßler, Mirjam

   2022 - Forschungsinformationssystem des UKE
2. Spontaneous Non-Sustained Ventricular Tachycardia and Premature Ventricular Contractions and Their Prognostic Relevance in Patients with Cancer in Routine Care

   1. Albrecht, Annemarie
   2. Porthun, Jan
   3. Eucker, Jan
   4. Coats, Andrew J S
   5. von Haehling, Stephan
   6. Pezzutto, Antonio
   7. Karakas, Mahir

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study

   1. Anker, Markus S
   2. von Haehling, Stephan
   3. Coats, Andrew J S
   4. Riess, Hanno
   5. Eucker, Jan
   6. Porthun, Jan
   7. Butler, Javed

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. The ACCOST-HH Trial:An investigator-initiated trial, the placebo-controlled, double-blind, multi-centre, randomized trial to assess the efficacy and safety of the antibody AdreCizumab (HAM8101) against plaCebO in SubjecTs witH cardiogenic sHock, (ACCOST-HH) in progress is discussed

   1. Skurk, Carsten
   2. Rottbauer, Wolfgang
   3. Kessler, Mirjam
   4. Akin, Ibrahim
   5. Kluge, Stefan
   6. Burdelski, Christoph
   7. Blankenberg, Stefan

   2020 - Forschungsinformationssystem des UKE
5. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

   1. Ray, Kausik K
   2. Landmesser, Ulf
   3. Leiter, Lawrence A
   4. Kallend, David
   5. Dufour, Robert
   6. Karakas, Mahir
   7. Hall, Tim

   2017 - Forschungsinformationssystem des UKE